CLINICAL TRIALS PROFILE FOR ACETYLCYSTEINE
✉ Email this page to a colleague
505(b)(2) Clinical Trials for acetylcysteine
Trial Type | Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|---|
OTC | NCT01005810 ↗ | A Trial of N-Acetylcysteine (an Over-the-Counter Medicine) in Adolescents Who Smoke Marijuana | Completed | National Institute on Drug Abuse (NIDA) | Phase 2 | 2009-09-01 | This study is investigating how N-Acetylcysteine (NAC), an over-the-counter medication, will reduce marijuana use when combined with Contingency Management, a behavioral treatment. It is hypothesized that marijuana dependent adolescents who are treated with NAC will use less marijuana during treatment when compared to adolescents who receive a placebo. |
OTC | NCT01005810 ↗ | A Trial of N-Acetylcysteine (an Over-the-Counter Medicine) in Adolescents Who Smoke Marijuana | Completed | Medical University of South Carolina | Phase 2 | 2009-09-01 | This study is investigating how N-Acetylcysteine (NAC), an over-the-counter medication, will reduce marijuana use when combined with Contingency Management, a behavioral treatment. It is hypothesized that marijuana dependent adolescents who are treated with NAC will use less marijuana during treatment when compared to adolescents who receive a placebo. |
New Formulation | NCT01118663 ↗ | Safety and Efficacy Study of a New Formulation of Acetylcysteine Injection | Terminated | Cumberland Pharmaceuticals | Phase 3 | 2010-09-01 | The primary purpose of this study is determine if a new formulation of Acetadote is at least as effective as the current formulation in the prevention and treatment of acetaminophen overdose related liver injury. |
>Trial Type | >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
All Clinical Trials for acetylcysteine
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00003346 ↗ | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma | Completed | National Cancer Institute (NCI) | Phase 2 | 1997-11-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of combination chemotherapy consisting of acetaminophen plus carmustine in treating patients who have stage III or stage IV melanoma. |
NCT00003346 ↗ | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma | Completed | Memorial Sloan Kettering Cancer Center | Phase 2 | 1997-11-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of combination chemotherapy consisting of acetaminophen plus carmustine in treating patients who have stage III or stage IV melanoma. |
NCT00004467 ↗ | Randomized Study of Acetylcysteine in Patients With Acute Liver Failure Not Caused by Acetaminophen | Completed | University of Texas | Phase 3 | 1998-06-01 | OBJECTIVES: I. Determine the safety and efficacy of a short course (72 hours) of intravenous acetylcysteine in patients with acute liver failure for whom no antidote or specific treatment is available. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for acetylcysteine
Condition Name
Clinical Trial Locations for acetylcysteine
Trials by Country
Clinical Trial Progress for acetylcysteine
Clinical Trial Phase
Clinical Trial Sponsors for acetylcysteine
Sponsor Name